Evidence map›Paper›PMID 34295228›Full record

ArticleFrontiers in behavioral neuroscience2021

Latent Sex Differences in CaMKII-nNOS Signaling That Underlie Antidepressant-Like Effects of Yueju-Ganmaidazao Decoction in the Hippocampus.

Ying Yin, Shiyu Qian, Yifan Chen, Yan Sun, Yuqiao Li, Yongfei Yu, Jianqing Li, Zhangjie Wu, Xinlang Yu, Rui Ge and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Ying YinKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Shiyu QianKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Yifan ChenKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Yan SunKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Yuqiao LiKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Yongfei YuKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Jianqing LiKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Zhangjie WuKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Xinlang YuKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Rui GeKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Jia HanKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Dongdong SunKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Haoxin WuKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Lanying LiuDepartment of Psychiatry, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Wenda XueKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Wei WangKey Laboratory of Integrative Medicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, China.
Nanjing University of Chinese Medicine · CNTongde Hospital of Zhejiang Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have demonstrated that Yueju-Ganmaidazao (YG) decoction induces rapid antidepressant-like effects, and the antidepressant response is mostly dependent on the suppression of nitric oxide-cyclic guanosine monophosphate signaling in male mice. This study aimed to investigate the sex difference mediated by calcium/calmodulin-dependent protein kinase II (CaMKII)-neuronal nitric oxide synthase (nNOS) signaling involved in the antidepressant-like effect of YG in mice. We found that the immobility times in the tail suspension test (TST) were found to be decreased after the single injection of YG in male and female mice with the same dosage. Additionally, chronic administration for 4 days of subthreshold dosage of YG and escitalopram (ES) also significantly decreased the immobility time in mice of both sexes. Chronic subthreshold dosage of YG and ES in LPS-treated mice and in chronic unpredictable stress (CUS) mice both decreased the immobility time, which was increased by stress. Meanwhile, in CUS-treated mice, sucrose preference test, forced swimming test, and open field test were applied to further confirm the antidepressant-like effects of YG and ES. Moreover, CUS significantly decreased the expression of nNOS and CaMKII, and both YG and ES could enhance the expression in the hippocampus of female mice, which was opposite to that in male mice, while endothelial nitric oxide synthase expression was not affected by stress or drug treatment neither in male mice nor in female mice. Finally, subthreshold dosage of YG combined with 7-nitroindazole (nNOS inhibitor) induced the antidepressant-like effects both in female and in male mice, while the single use of YG or 7-NI did not display any effect. However, pretreatment with KN-93 (CaMKII inhibitor) only blocked the antidepressant-like effect of high-dosage YG in female mice. Meanwhile, in CUS mice, chronic stress caused NR1 overexpression and inhibited cAMP response element binding protein action, which were both reversed by YG and ES in male and female mice, implying that YG and ES produced the same antidepressant-like effect in mice of both sexes. The study revealed that chronic treatment with a subthreshold dose of YG also produced antidepressant-like effects in female mice, and these effects depended on the regulation of the CaMKII-nNOS signaling pathway.

Indexed as

CaMKIICREBnNOSsex differenceYG

Identifiers

PMID34295228
PMCPMC8290083
OpenAlexW3179271679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.